/
/
/

Brooks Laboratories Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)65.95
Volume (₹)11,814.00
High (₹)66.68
Upper Circuit67.35
Low (₹)64.00
Lower Circuit60.95
Prev Close64.15
52W High (₹)163.90
Price64.99
52W Low (₹)36.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)189.17 Cr
Div. Yield (%)0.00
PE Ratio14.32
Debt to Equity0.06
Price to Book0.90
Book Value41.64
EPS (TTM)4.49
Face Value10.00
ROE (%)22.27

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
BROOKS-BENSE
LTP
1W Low
1W High
Market cap (₹)
1901.6-18.4 (-0.96%)
1900.10
1984.80
4,56,833Cr
9182.5-56.5 (-0.61%)
9087
9467
2,45,426Cr
4859.5-190.5 (-3.77%)
4854
5066
1,87,320Cr
1131.7-59.3 (-4.98%)
1125.10
1187
1,13,217Cr
1380.8-42.7 (-3.00%)
1376.70
1426.10
1,12,212Cr
1852.1-86.4 (-4.46%)
1811.70
1949
1,01,155Cr
2122.5-49 (-2.26%)
2118.10
2192
97,626Cr
2335.6-47.3 (-1.98%)
2335
2419.20
96,859Cr
1162-16 (-1.36%)
1154.40
1179.90
96,406Cr
1659.3+14 (0.85%)
1622.60
1717
93,614Cr
64.99-4.29 (-6.19%)
64
71.40
189Cr

Key Highlights of Brooks Laboratories Ltd Balance Sheet

Brooks Laboratories Ltd balance sheet discloses shareholders' funds of ₹29.46Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹29.46Cr, and the reserves and surplus of the company is ₹91.39Cr.

The company has its non-current liabilities with total liabilities of ₹146.36Cr as of 2026-03-31.

The current liabilities are ₹21.81Cr as of 2026-03-31. At the same time, current assets are ₹37.42Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹90.53Cr and tangible assets of ₹14.52Cr, provided in the Brooks Laboratories Ltd financial statements.